Cannabis Abuse as a Risk Factor for Depressive Symptoms

University of Pennsylvania Treatment Research Center, Philadelphia, PA 19104, USA.
American Journal of Psychiatry (Impact Factor: 12.3). 01/2002; 158(12):2033-7. DOI: 10.1176/appi.ajp.158.12.2033
Source: PubMed


This study sought to estimate the degree to which cannabis abuse is a risk factor for depressive symptoms rather than an effort to self-medicate depression.
Participants (N=1,920) in the 1980 Baltimore Epidemiologic Catchment Area (ECA) study who were reassessed between 1994 and 1996 as part of a follow-up study provided the data. The analysis focused on two cohorts: those who reported no depressive symptoms at baseline (N=849) and those with no diagnosis of cannabis abuse at baseline (N=1,837). Symptoms of depression, cannabis abuse, and other psychiatric disorders were assessed with the Diagnostic Interview Schedule.
In participants with no baseline depressive symptoms, those with a diagnosis of cannabis abuse at baseline were four times more likely than those with no cannabis abuse diagnosis to have depressive symptoms at the follow-up assessment, after adjusting for age, gender, antisocial symptoms, and other baseline covariates. In particular, these participants were more likely to have experienced suicidal ideation and anhedonia during the follow-up period. Among the participants who had no diagnosis of cannabis abuse at baseline, depressive symptoms at baseline failed to significantly predict cannabis abuse at the follow-up assessment.
Further research is needed to identify characteristics of individuals who abuse cannabis that account for their higher risk of depression to estimate the degree of impairment resulting from their depression.

Download full-text


Available from: Gregory Bovasso, Apr 22, 2014
  • Source
    • "The prevalence of prescription opioid dependence in the United States has increased considerably in the past two decades (Johnston et al., 2011; Substance Abuse and Mental Health ServicesAdministration, 2013). According to the Centers for Disease Control and Prevention, the annual quantity of painkillers prescribed in the Anhedonia has been found to be a common symptom of the abstinence syndrome associated with both acute and protracted withdrawal in substance-dependent populations (Bovasso, 2001;Gawin and Ellinwood, 1988;Garfield et al., 2014;Hatzigiakoumis et al., 2011;Heinz et al., 1994;Leventhal et al., 2009Leventhal et al., , 2010Loas, 1996;Martinotti 2008b), including opiate-dependence (Martin et al., 1963;Martin et al., 1973;Zijlstra et al., 2009). Emotional disturbances , including anhedonia, have been thought to contribute to the high rates of relapse (Alling et al., 1982;Begleiter and Porjesz, 1979;Martin et al., 1963Martin et al., , 1973). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Anhedonia is an important but understudied element of a neuroadaptive model underlying vulnerability to relapse in opioid dependence. Previous research using fMRI has shown reduced activation to pleasant stimuli in rostral prefrontal cortex among heroin-dependent patients in early recovery. This study evaluated the presence of anhedonia among recently withdrawn prescription opiate dependent patients (PODP) in residential treatment compared to control subjects. Anhedonia was assessed using self-report, affect-modulated startle response (AMSR), and a cue reactivity task during which participant's rostral prefrontal cortex (RPFC) and ventrolateral prefrontal cortex (VLPFC) was monitored with functional near infrared spectroscopy (fNIRS). The cue reactivity task included three distinct categories of natural reward stimuli: highly palatable food, positive social situations, and intimate (non-erotic) interactions. PODP reported greater anhedonia on self-report (Snaith-Hamilton Pleasure Scale), and showed reduced hedonic response to positive stimuli in the AMSR task relative to controls. PODP also exhibited reduced neural activation in bilateral RPFC and left VLPFC in response to food images and reduced left VLPFC in response to images depicting positive social situations relative to controls. No differences were found for emotionally intimate stimuli. When patients were divided into groups based on the Snaith-Hamilton criteria for the presence or absence of anhedonia, patients endorsing anhedonia showed reduced neural responses to images depicting positive social stimuli and food relative to patients who did not endorse anhedonia. Activations were in areas of RPFC that support the retrieval of episodic memories. The results suggest the presence of anhedonia in a subsample of PODP.
    Full-text · Article · Dec 2015 · Brain research bulletin
    • "The comorbid presentation of drug abuse and depression is relatively common in clinical and community populations . Evidence indicates that psychopathology is a risk factor for drug use (Bovasso, 2001; Brook, Cohen, & Brook, 1998; Conner, Pinquart, & Duberstein, 2008; Deykin, Levy, & Wells, 1987; Wild, 2005). In the United States, the prevalence of current depression and lifetime depression among the general population is around 7% and 16%, respectively (Pratt & Brody, 2008; Strine, 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: The prevalence of depression among drug users is high. It has been recognized that drug use behaviors can be influenced and spread through social networks. Objectives: We investigated the directional relationship between social network factors and depressive symptoms among a sample of inner-city residents in Baltimore, MD. Methods: We performed a longitudinal study of four-wave data collected from a network-based HIV/STI prevention intervention for women and network members, consisting of both men and women. Our primary outcome and exposure were depression using CESD scale and social network characteristics, respectively. Linear-mixed model with clustering adjustment was used to account for both repeated measurement and network design. Results: Of the 746 participants, those who had high levels of depression tended to be female, less educated, homeless, smokers, and did not have a main partner. In the univariate longitudinal model, larger size of drug network was significantly associated with depression (OR = 1.38, p < .001). This relationship held after controlling for age, gender, homeless in the past 6 months, college education, having a main partner, cigarette smoking, perceived health, and social support network (aOR = 1.19, p = .001). In the univariate mixed model using depression to predict size of drug network, the data suggested that depression was associated with larger size of drug network (coef. = 1.23, p < .001) and the same relation held in multivariate model (adjusted coef. = 1.08, p = .001). Conclusions: The results suggest that larger size of drug network is a risk factor for depression, and vice versa. Further intervention strategies to reduce depression should address social networks factors.
    No preview · Article · Nov 2015 · Substance Use & Misuse
    • "Exposure to an urban environment (Vassos et al. 2012), early childhood trauma (Varese et al. 2012) and cannabis use (Minozzi et al. 2010) are consistently associated with psychotic outcome in rigorously designed epidemiological studies, including prospective studies, in both clinical and general populations. Confirming the shared vulnerability theory of psychopathology , environmental factors, particularly cannabis use and trauma, are also associated with affective disorders, albeit less pronounced (Bovasso, 2001; Moore et al. 2007; Breetvelt et al. 2010; Nanni et al. 2012; Kedzior & Laeber, 2014). Similarly, a nationwide "
    [Show abstract] [Hide abstract]
    ABSTRACT: Evidence suggests that in affective, non-psychotic disorders: (i) environmental exposures increase risk of subthreshold psychotic experiences (PEs) and strengthen connectivity between domains of affective and subthreshold psychotic psychopathology; and (ii) PEs are a marker of illness severity. In 3021 adolescents from the Early Developmental Stages of Psychopathology cohort, we tested whether the association between PEs and presence of DSM-IV mood disorder (MD)/obsessive-compulsive disorder (OCD) would be moderated by risk factors for psychosis (cannabis use, childhood trauma and urbanicity), using the interaction contrast ratio (ICR) method. Furthermore, we analysed whether the interaction between environment and PEs was mediated by non-psychotic psychopathology. The association between PEs and MD/OCD was moderated by urbanicity (ICR = 2.46, p = 0.005), cannabis use (ICR = 3.76, p = 0.010) and, suggestively, trauma (ICR = 1.91, p = 0.063). Exposure to more than one environmental risk factor increased the likelihood of co-expression of PEs in a dose-response fashion. Moderating effects of environmental exposures were largely mediated by the severity of general non-psychotic psychopathology (percentage explained 56-68%, all p < 0.001). Within individuals with MD/OCD, the association between PEs and help-seeking behaviour, as an index of severity, was moderated by trauma (ICR = 1.87, p = 0.009) and urbanicity (ICR = 1.48, p = 0.005), but not by cannabis use. In non-psychotic disorder, environmental factors increase the likelihood of psychosis admixture and help-seeking behaviour through an increase in general psychopathology. The findings are compatible with a relational model of psychopathology in which more severe clinical states are the result of environment-induced disturbances spreading through a psychopathology network.
    No preview · Article · Mar 2015 · Psychological Medicine
Show more